{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:03:29Z","timestamp":1784783009449,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"\n Introduction<\/jats:title>\n Sickle cell retinopathy is a consequence of sickle cell disease that results from vascular complications. Sickle cell disease is predominantly prevalent in Africa, evidenced by 20% to 30% of the population in Gabon, Cameroon, and Ghana being affected by it. This systematic review aims to evaluate the surgical outcomes of patients with sickle cell retinopathy to inform evidence-based management of late stages of sickle cell retinopathy.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This systematic review was conducted in accordance with the PRISMA 2020 guidelines. A Literature search was conducted on PubMed, Embase (Ovid), and Cochrane (CENTRAL) on 05\/08\/2025. Inclusion criteria included studies with patients with sickle cell retinopathy who underwent surgery and reported anatomical and\/or visual outcomes. A random effects single-arm meta-analysis was carried out in the anatomical success group using JASP software, and the risk of bias was evaluated using JBI and RoB2 tools.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n 7 studies, comprising 408 eyes, were included. Overall, the evidence showed that surgical treatment in patients with sickle cell retinopathy results in improved final visual acuity and high single-surgery anatomical success (SSAS, between 60% to 83%). The pooled SSAS data, based on logit-transformed proportions, yielded an effect of 0.83 (95% CI: 0.24\u20131.42), corresponding to a pooled SSAS of approximately 70% (95% CI: 56\u201380%), with low, non-significant heterogeneity among the included studies (Q (4) = 5.61, p = 0.230; I\u00b2 = 29.73% [0.00, 92.46]). Leave-one-out sensitivity analysis confirmed that the estimate was robust, with the pooled SSAS ranging from approximately 66% to 74% across iterations.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n Studies have reported a considerable gain in final visual acuity and anatomical success in patients undergoing surgery for sickle cell retinopathy. The small number of studies and small sample sizes increase heterogeneity. Therefore, although the results indicate favourable surgical outcomes, clinicians must weigh up the benefits of surgery against possible complications. In conclusion, more studies are warranted to guide evidence-based medicine.<\/jats:p>\n <\/jats:sec>\n \n Systematic review registration<\/jats:title>\n \n https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251165357<\/jats:ext-link>\n , identifier CRD420251165357.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fopht.2026.1842211","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:32Z","timestamp":1784780912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical management of sickle cell retinopathy: a systematic review of clinical outcomes and a single-arm meta-analysis of single-surgery anatomical success"],"prefix":"10.3389","volume":"6","author":[{"given":"Maher","family":"Nassor","sequence":"first","affiliation":[{"name":"School of Medicine, University of Sunderland","place":["Sunderland, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bakr","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Muhammad","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Tahoun","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Manchester","place":["Manchester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286420","article-title":"Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidence","volume":"110","author":"Brandsen","year":"2025","journal-title":"Haematologica"},{"key":"B2","volume-title":"Sickle cell disease","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009147","article-title":"Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study","volume":"7","author":"Brandsen","year":"2023","journal-title":"Blood Adv"},{"key":"B4","article-title":"Sickle cell retinopathy [Internet","volume-title":"Eyerounds.Org","author":"Alawa","year":"2016"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.06.007","article-title":"Incidence and natural history of proliferative sickle cell retinopathy","volume":"112","author":"Downes","year":"2005","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40942-022-00417-7","article-title":"Anatomical and functional outcomes of retinal detachment associated with nontraumatic giant retinal tears compared to simple rhegmatogenous retinal detachment","volume":"8","author":"Garneau","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"B8","article-title":"Rayyan: intelligent systematic review","volume-title":"Rayyan","year":"2022"},{"key":"B9","article-title":"PRISMA 2020 flow diagram","volume-title":"Prisma","year":"2020"},{"key":"B10","article-title":"Checklist for case series","volume-title":"Jbi","year":"2020"},{"key":"B11","article-title":"RoB 2: a revised Cochrane risk-of-bias tool for randomized trials","volume-title":"Cochrane","year":"2019"},{"key":"B12","article-title":"robvis: risk-of-bias visualization [Internet","author":"McGuinness","year":"2023"},{"key":"B13","article-title":"JASP: a fresh way to do statistics","volume-title":"Jasp","year":"2025"},{"key":"B14","article-title":"Identifying and measuring heterogeneity","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004145","article-title":"Surgical outcomes of retinal detachment associated with proliferative sickle cell retinopathy","volume":"44","author":"Ahmed","year":"2024","journal-title":"Retina"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2024.01.014","article-title":"Proliferative sickle cell retinopathy: outcomes of vitreoretinal surgery","volume":"8","author":"Rohowetz","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"B17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ajo.2013.12.005","article-title":"Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series","volume":"157","author":"Chen","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231199273","article-title":"Visual outcome of treating proliferative sickle cell retinopathy in 108 eyes","volume":"34","author":"Okonkwo","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/112067210801800213","article-title":"Retinal photocoagulation for proliferative sickle cell retinopathy: a prospective clinical trial with new sea fan classification","volume":"18","author":"Sayag","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.296","article-title":"Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy","volume":"23","author":"Williamson","year":"2009","journal-title":"Eye (Lond)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0127-y","article-title":"A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy: clinical outcomes and surgical management","volume":"32","author":"Ho","year":"2018","journal-title":"Eye (Lond)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.78.9.681","article-title":"New classification of peripheral retinal vascular changes in sickle cell disease","volume":"78","author":"Penman","year":"1994","journal-title":"Br J Ophthalmol"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1842211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:37Z","timestamp":1784780917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1842211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":22,"alternative-id":["10.3389\/fopht.2026.1842211"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1842211","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1842211"}}